- About MyVHL: Patient Natural History Study
Frequently Asked Questions
MyVHL is available in English and Spanish. You can choose your preferred language when you register.
The MyVHL: Patient Natural History Study is collecting information about von Hippel-Lindau (VHL), Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), Birt-Hogg-Dubé (BHD), Succinate Dehydrogenase Complex Subunit B (SDHB) and other related conditions in hopes of finding a cure for these diseases as well as related kidney and adrenal tumors. Learning about their similarities and differences will help scientists understand how these genes work in the cell, and how we might intervene and make a difference.
Von Hippel-Lindau (VHL) is a disease which causes tumors in multiple parts of the body. Since the discovery of the VHL gene in 1993, progress has been made in understanding the processes within the cell governed by the VHL gene. The series of processes (or pathways) controlled by VHL also include the genes for Birt-Hogg-Dubé (BHD), Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), and Succinate Dehydrogenase Complex Subunit B (SDHB), three other genetic kidney cancer syndromes. Drugs to assist in management of these diseases are beginning to emerge and will need to go through clinical trials to evaluate their effectiveness.
These diseases are rare, which makes it difficult to gather information and develop treatments. The MyVHL: Patient Natural History Study will collect information from patients all over the world and could help researchers have a better understanding of VHL and associated diseases. The rarity of these diseases makes it difficult to conduct large clinical trials. To address these deficiencies, the VHL Alliance, in collaboration with the National Organization for Rare Disorders (NORD), has developed a patient databank to collect detailed medical information on patients with VHL, BHD, HLRCC, SDHB and related tumors, to help discover possible factors contributing to disease pathogenesis/progression, and to help evaluate efficacy of novel therapies.
For more information, visit: vhl.org/MyVHL.
Top of Page
By participating in the MyVHL: Patient Natural History Study, you become part of a community created to energize, inform, engage and support VHL, BHD, and HLRCC research. We come together to help find better treatments, more quickly. When you add your voice, VHLA makes a steadfast promise:
- We promise to safeguard your information and protect your privacy.
- We promise that you own your health information, forever.
- We promise that you control who can access your health information.
- We promise not to share your contact information or identifying information, unless you tell us to reveal it.
- We promise to honor your preferences about the types of information we send you.
- We promise that you can stop participating in MyVHL at any time and have your information removed from the registry.
- We promise to do everything we can to ensure patient voices are heard.
Top of Page
Frequently Asked Questions
- What is a patient registry?
- A patient registry is a collection of information about individuals, usually focused around a specific diagnosis or condition, that is provided by the patients themselves. Registries can help lay the foundation for future research and promote better understanding of a disease.
- The difference between a patient registry and one that is clinician/researcher driven is that in a patient registry, all data is voluntarily provided and submitted by the patient. This allows us the opportunity to encourage collaboration between researchers and institutions.
- Why are patient registries needed?
- Patient registries can provide health care professionals and researchers with first-hand information about people with certain conditions, both individually and as a group, and over time, to increase our understanding of that condition.
- What types of data are collected in MyVHL?
- All types of data can be collected, including data related to the following:
- Natural history data that captures longitudinal information about the disease
- Diagnosis and treatment
- Management of care
- Quality of life
- Clinical testing samples
- Clinician reporting
- Healthcare providers
- It sounds like these registries collect personal health information. Is there a risk that such information could be disclosed?
- Government agencies have strict privacy requirements set by law such as the Federal Information Security Management Act (FISMA), and the Health Insurance Portability and Accountability Act (HIPAA). The likelihood of identifiable personal information being shared is very small. VHLA promises to never share your data with anybody without your consent.
- What benefits will someone receive from participating in MyVHL?
- Participation in MyVHL is likely to increase what we know about VHL, help health care professionals improve treatment, and allow researchers to design better studies, including development and testing of new treatments. Individuals (and their families) who choose to participate should understand that participation will not guarantee a treatment or cure for VHL.
- Additionally, in order to show our appreciation for your help in participating in MyVHL toward finding a cure, VHLA will provide a $50 Amazon gift card to all US-based participants with VHL who complete all of their applicable surveys, as well as submit scans and/or a signed Records Release Form.
- How do I receive my $50 Amazon gift card?
- To receive your Amazon gift card, all you have to do is click Participate, register/login to MyVHL, complete and submit all of the applicable surveys and upload scans and/or a signed Records Release Form. Once you have completed all of the steps, you will be contacted by a VHLA staff member to thank you for participating and to send you your gift. Please note that you must have VHL and be based in the United States in order to receive the gift card.
- How are the data collected?
- The data are collected online by patients that register and grant consent to enter their own personal data or the data on behalf another participant, if he or she is legally authorized to do so.
- Can data be collected worldwide?
- Yes, MyVHL can be accessed from anywhere in the world, and international participation by the patient community and research collaborations are supported and encouraged.
- Who has access to the information in a registry?
- The data in MyVHL is accessible only to qualified and trained VHLA staff. Any outside requests for de-identified data must first go through a review process and be approved by the MyVHL Research Committee. No identifiable data will ever be shared with anyone.
- Who owns the data from a registry? Who makes decisions about how these data will be used?
- The data collected in a disease registry is stripped of personal information. It belongs to the VHL Alliance. Personal identifying information is kept private. The MyVHL Research Committee makes decisions about how the de-identified data can be used or shared.
- Will anyone else know my name?
- Your personal information such as your name, address, or other information that identifies you or your family will be labeled with a code number, encrypted, stored in a secure place and protected with a password. Only qualified and trained VHLA staff will have access to the code and be able to identify you, if needed. Your identifiable information will not be shared with anyone outside of VHLA. Approved scientists, researchers, and clinicians, will be given only the de-identified information and may search the de-identified data for patients for their studies. We call this information “de-identified” because all personal identifiers have been removed.
- All other information (such as hard copies of records) will be stored in locked files and destroyed in accordance to the standards established by the HIPAA Privacy Act. To review the entire HIPAA Privacy Act, and for information about how it applies to patients, see the Office for Civil Rights website.
- Can insurance companies access my medical information and/or my participation in this study?
- No, insurance companies are not and will not be granted access to research records. Participants do not have to tell their health insurance companies that they have participated in a research project. Research is different from clinical care. Research records are not a part of a person’s medical record.
- The Genetic Information Nondiscrimination Act (GINA) of 2008 is intended to prohibit the improper use of genetic information. GINA provides comprehensive protection to individuals so that they may avail themselves of genetic diagnostic tests for the advancement of their individualized medical care without the threat of discrimination from insurance companies based on their personal genetic makeup. To review the entire Genetic Information Nondiscrimination Act of 2008 and other helpful information regarding GINA, go to http://www.genome.gov/11510239.
- Can a participant withdraw from MyVHL?
- Yes. MyVHL is free and voluntary; there is no penalty for choosing to withdraw at any point.
- How is MyVHL different from a clinical trial?
- MyVHL collects information voluntarily from people with VHL, BHD, SDH and HLRCC.
- A clinical trial is the study of new ways to prevent, detect or treat diseases or conditions. Participating in MyVHL does not mean a person has signed up for a clinical trial.
Top of Page
If you experience any difficulties with MyVHL, please email: MyVHL@vhl.org or call: 617-277-5667 x4.
Top of Page